Guides & protocols, with sources.

The two completely different dosing conventions circulating for 5-Amino-1MQ, why they sit about a hundredfold apart, and how to tell which one applies to what you bought.

The daily amounts people actually run for AOD-9604, the joint-health angle that has outlasted the fat-loss one, and an honest account of why this compound never became a drug.

ARA-290 is one of the very few compounds here with real human research behind it, and that research found a specific amount that worked and a higher one that didn't.

The amount most people actually run for BPC-157, where that number really comes from, how it's cycled and stacked, and how it compares to TB-500 if you're weighing the two.

The weekly titration people actually run for research-grade cagrilintide, how it's paired with semaglutide, and what the trial data says it does on its own.

Two different compounds are sold under this one name, one injected weekly and one daily, and they're dosed twenty times apart. Here's what people run on each, and which version a given number belongs to.

The most commonly run pairing in the growth hormone family, the ratio problem nobody mentions when they sell you a premixed vial, and how to compare blend prices that aren't measured the same way.

The nightly amounts people actually run for DSIP, why the vial you buy probably outlasts its own shelf life, and what the compound's name promises that the research didn't deliver.

The course structure people actually run for Epithalon, how to cycle and stack it, and how it stacks up against DSIP if sleep, not longevity, is the actual goal.

How people actually run GHK-Cu by injection, from reconstitution to cycling to how it stacks up against the topical serums it's better known for.

The GHK-Cu, BPC-157 and TB-500 blend sold for skin, what the 70 mg vial actually contains, and why the skin component is the one usually used a different way.

The nightly amounts people actually run for Ipamorelin, why it's the one compound in this family that doesn't make you hungry, and how it compares to GHRP-2.

How to dose a fixed-ratio four-peptide blend, the reconstitution math that changes all four components at once, how it's cycled, and how it compares to the three-peptide GLOW blend it's built from.

The amounts people run for KPV, why this is one of the few peptides here with a real argument for swallowing it, and how it compares to BPC-157.

The loading and maintenance amounts people run for Melanotan II, the skin check this compound genuinely requires, and why PT-141 exists.

The amount most commonly discussed for MOTS-c, why none of it traces to a human trial, how it's cycled and stacked, and how it compares to SS-31 if you're weighing the two.

The dosing patterns people actually describe for injectable NAD+, NMN, and NR, how each is cycled, and how the injectable route compares to Epithalon if you're weighing two different longevity angles.

The on-demand dosing pattern people actually run for PT-141, why it isn't a cycling compound the way most of this site is, and how it compares to Melanotan II if you're weighing the two.

The weekly escalation schedule people actually run for retatrutide, how it's stacked and cycled, and how it stacks up against tirzepatide if you're weighing the two.

The amounts and short courses people run for selank, why the nasal spray is the form the evidence actually belongs to, and how it compares to semax.

The titration schedule people actually run for research-grade semaglutide, how it's cycled and stacked, and how it stacks up against tirzepatide if you're weighing the two.

The amounts and short courses people run for semax, why the nose is the route the human evidence actually used, and how it compares to selank.

The nightly amounts people run for sermorelin, the approved product it used to be and why that ended, and the legal route to it that most of this market doesn't have.

The amount most commonly discussed for SS-31, why it sits far below the dose that was actually tested in trials, how it's cycled and stacked, and how it compares to MOTS-c.

The loading-then-maintenance pattern almost everyone quotes for TB-500 has no traceable source. Here's the schedule most commonly referenced, where it likely actually comes from, and how TB-500 compares to BPC-157.

The daily amounts people actually run for research-grade tesamorelin, why the schedule eats vials faster than almost anything else on this site, and how it compares to CJC-1295.

The amounts people run for Thymosin Alpha-1, why 1.6 mg keeps appearing, and the difference between waking the immune system up and calming it down.

The titration schedule people actually run for research-grade tirzepatide, how it's cycled and stacked, and how it stacks up against semaglutide if you're weighing the two.

VIP arrives as a vial of powder for injection, and almost every dosing pattern in circulation was written for a compounded nasal spray. Knowing which one you're reading is most of the work.

The BPC-157 and TB-500 pairing, why a premixed vial forces two compounds with different rhythms onto one schedule, and what people run anyway.